Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 3.650
-0.010 (-0.27%)
Apr 2, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Revenue
In the year 2025, Hua Medicine (Shanghai) had annual revenue of 492.93M CNY with 92.63% growth. Hua Medicine (Shanghai) had revenue of 275.50M in the half year ending December 31, 2025, with 4,287.67% growth.
Revenue
492.93M CNY
Revenue Growth
+92.63%
P/S Ratio
6.59
Revenue / Employee
1.73M CNY
Employees
285
Market Cap
3.62B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 492.93M | 237.04M | 92.63% |
| Dec 31, 2024 | 255.89M | 179.28M | 234.02% |
| Dec 31, 2023 | 76.61M | 59.01M | 335.31% |
| Dec 31, 2022 | 17.60M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chia Tai Enterprises International | 4.17B |
| SSY Group | 4.17B |
| China Shineway Pharmaceutical Group | 3.49B |
| Edding Genor Group Holdings | 2.77B |
| Essex Bio-Technology | 1.81B |
| Jacobson Pharma Corporation | 1.53B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.51B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |